Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Anand Kamal Singh"'
Publikováno v:
Cells, Vol 12, Iss 3, p 365 (2023)
Immunotherapy has brought new hope for cancer patients in recent times. However, despite the promising success of immunotherapy, there is still a need to address major challenges including heterogeneity in response among patients, the reoccurrence of
Externí odkaz:
https://doaj.org/article/b07324bb4ffb40eab0421b8c0537f1a7
Supplementary Table 1. Differentially methylated genes in correlation with their expression pattern in the A4 progression model Supplementary Table 2. Genes enriched for different histone methylation marks in A4 progression model identified through C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a630aa38f6f6be2bb386f9a5873c0e0
https://doi.org/10.1158/1078-0432.22454906.v1
https://doi.org/10.1158/1078-0432.22454906.v1
Purpose: Resolution of aberrant epigenetic changes leading to altered gene expression during transformation and tumor progression is pertinent for mechanistic understanding of disrupted pathways in cancer. Such changes provide for biomarkers that can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a8ea37c98bb4cf838a75adf6f1ee5ed
https://doi.org/10.1158/1078-0432.c.6522869.v1
https://doi.org/10.1158/1078-0432.c.6522869.v1
Supplementary Fig.1. Flow chart of approach for identification of progression associated biomarkers based on differential promoter methylation Supplementary Fig.2a. Venn diagram representing hypo- and hyper-methylated genes in the A4 progression mode
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4345d65e8596dcc3aa2f588814dc9cd
https://doi.org/10.1158/1078-0432.22454909
https://doi.org/10.1158/1078-0432.22454909
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 21(22)
Purpose: Resolution of aberrant epigenetic changes leading to altered gene expression during transformation and tumor progression is pertinent for mechanistic understanding of disrupted pathways in cancer. Such changes provide for biomarkers that can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aafad658272d23442ac18331790f69d5
https://pubmed.ncbi.nlm.nih.gov/26130461
https://pubmed.ncbi.nlm.nih.gov/26130461
Autor:
Anita Mann, Munia Ganguli, Namita Kalra, Anand Kamal Singh, Richa Khanduri, Vasundhara Shukla, Bilikere S. Dwarakanath, Garima Thakur, Rangeetha Naik, Ülo Langel, Yang Jiang
Designing of nanocarriers that can efficiently deliver therapeutic DNA payload and allow its smooth intracellular release for transgene expression is still a major constraint. The optimization of DNA nanocarriers requires thorough understanding of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a968a772583d2f6971b6268304e31d82
https://doi.org/10.5167/uzh-49551
https://doi.org/10.5167/uzh-49551